Pregnancy outcomes after maternal exposure to rituximab.
about
Hematologic malignancies during pregnancy: A reviewAntirheumatic drugs and reproduction in women and men with chronic arthritisImmunosuppressive drugs and fertilityContemporary management of primary immune thrombocytopenia in adultsTo B or not to B cells-mediate a healthy start to lifeUpdated consensus statement on the use of rituximab in patients with rheumatoid arthritis.Management of rheumatoid arthritis during pregnancy: challenges and solutionsChallenges and treatment options for rheumatoid arthritis during pregnancy.Diagnosis and management of maternal thrombocytopenia in pregnancy.Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.Multidisciplinary approach in pregnancy-associated thrombotic thrombocytopenic purpura: a case reportManagement of thrombocytopenia.Thrombocytopenic syndromes in pregnancy.Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive managementA best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to knowSafety of monoclonal antibodies for the treatment of multiple sclerosis.Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximabFetal outcomes after rituximab exposure in women with autoimmune vasculitisChronic lymphocytic leukaemia during pregnancy: management and thoughtsPlace in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.Cytomegalovirus in the neonate: immune correlates of infection and protectionExperience with rituximab in the treatment of antineutrophil cytoplasmic antibody associated vasculitisCharacterization of the Highly Prevalent Regulatory CD24hiCD38hi B-Cell Population in Human Cord Blood.Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.Safety of biologic therapy in rheumatoid arthritis.Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.Are monoclonal antibodies a safe treatment for cancer during pregnancy?Effects of fetal exposure to maternal chemotherapy.Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases.An update on the management of hematologic malignancies in pregnancy.Current and prospective pharmacotherapy for autoimmune hepatitis.Safety considerations when prescribing immunosuppression medication to pregnant women.Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management.Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth.High-risk pregnancy and the rheumatologist.Management of Hematologic Malignancies: Special Considerations in Pregnant Women.
P2860
Q26740587-AB5E34FE-42BF-401A-B781-FD34DB47F32AQ26777914-2677816B-0B38-4F7F-AE4E-E0C4F06F91BDQ26778587-E28E89B0-4161-46D2-A919-36D38A60404BQ26853680-A3847493-474B-4F59-9D28-56172C893C86Q27024986-3C4990D6-1B55-4EF7-BABF-6D569C3E5D2EQ27691388-918878BF-21DA-410E-8397-BF6466B3489FQ28068678-63219E24-E83C-4FAF-9B5A-7088F79505C6Q30249730-3EC88948-3B8A-45BA-A54C-0B993EB18FC8Q33401045-DF22B296-0C70-4D9B-9858-81713755D048Q33401130-1E0672BD-67B6-4B8D-BC21-9B06107AB4A2Q33401403-B60411D6-6177-47ED-8A8B-D28783B6AE86Q33405115-561F9AEF-020C-4067-8D42-2945B51F2A0AQ33409187-8754FC23-C840-422D-A31A-A93AA1378C7FQ33416258-66227DC4-6FAB-412E-8D15-D04B5A060972Q33434497-633884F4-FBAB-40EF-8B3C-5B42D88D3735Q33774671-4CBFF62A-0EA9-4848-BB66-48870E9FE64BQ33844319-AF6763BB-ABEF-46BF-B43F-155AFE5F2E75Q33854868-AACC48B3-5176-4AC1-AE1F-00EE911FB1AAQ34389362-AA10CF90-9562-499A-9AC4-0901F1905E32Q34542922-493AADF4-CC03-4A98-8A13-509E3D4AC31BQ35065425-A2A26EBF-DE2D-4D00-89A3-F72B597125D9Q35535231-22A33DB2-144D-4A4E-AE5C-2A9A86F9A2C2Q36319427-323AA9B3-14A2-438E-AEEE-1AA2F497A943Q37031689-AB5A0DA0-BAE8-4606-823E-6EA8F05AA43CQ37140130-38E9D198-1138-4F74-AF0A-6468324B1C19Q37640836-E33604C9-15D7-41BE-AFAC-87E365B4A0E9Q37683167-CF0E2CCB-69BA-43DD-8750-F4E3B669A2EFQ37943826-CBF3DCCB-721D-435E-9056-B08A91735D12Q37944433-F8708759-7CE8-481F-BFFC-4D161AA86FD8Q38074086-D79C484A-2830-4338-96F4-DD3C7D40D7F1Q38119550-DD55CA7A-935C-40EC-AAF6-689ED7BBC1EEQ38121738-04E83D0D-2C95-456D-B536-3410A0B6E307Q38208275-43E297B1-B5FD-4D3E-A0A6-B95F5284DD4AQ38222515-84A7CAA6-FD38-4222-BA3D-DE22A0EF2D76Q38222882-540872EB-FC28-49B7-A68D-8C53B3885A9BQ38246109-F6ABE828-EA80-4950-99CA-052AAC2055E5Q38254406-1209958A-EC01-4E49-923A-A2E5F01A5A2AQ38282115-E8E7B58D-C239-441B-B5BC-DACDF4F00E57Q38283472-B3F66B00-0935-402C-BEA7-894749289B20Q38594889-B47CE91B-2F8F-4806-AA22-219A4517A63E
P2860
Pregnancy outcomes after maternal exposure to rituximab.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pregnancy outcomes after maternal exposure to rituximab.
@ast
Pregnancy outcomes after maternal exposure to rituximab.
@en
type
label
Pregnancy outcomes after maternal exposure to rituximab.
@ast
Pregnancy outcomes after maternal exposure to rituximab.
@en
prefLabel
Pregnancy outcomes after maternal exposure to rituximab.
@ast
Pregnancy outcomes after maternal exposure to rituximab.
@en
P2093
P1433
P1476
Pregnancy outcomes after maternal exposure to rituximab.
@en
P2093
Ariella Kelman
Elaine R Murray
Eliza F Chakravarty
Pamela Farmer
P304
P356
10.1182/BLOOD-2010-07-295444
P407
P577
2010-11-23T00:00:00Z